Breaking News Instant updates and real-time market news.

SPX

S&P 500

/

+

, VIX

Volatility Index S&P 500 Options

/

+

09:18
06/24/21
06/24
09:18
06/24/21
09:18

Overnight activity included 1034 trades in SPX and 30 trades in VIX

1034 trades were executed in SPX overnight, totaling 10072 contracts, with 66.8% of the volume marked spread. 30 trades were executed in VIX overnight, totaling 334 contracts, with 0.6% of the volume marked spread.

SPX

S&P 500

/

+

VIX

Volatility Index S&P 500 Options

/

+

SPX S&P 500
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
VIX Volatility Index S&P 500 Options
/

+

TODAY'S FREE FLY STORIES

Earnings
Aligos Therapeutics reports Q2 EPS (79c), consensus (81c) » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ALGS

Aligos Therapeutics

$16.31 /

+0.85 (+5.50%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

07/08/21 Piper Sandler
Aligos should be bought into 'catalyst rich' second half, says Piper Sandler
06/21/21 Piper Sandler
Aligos reported 'robust data' in hepatitis B virus, says Piper Sandler
06/10/21 Piper Sandler
Aligos Therapeutics has data-rich month with robust lineup, says Piper Sandler
05/17/21 Piper Sandler
Aligos Therapeutics assumed with an Overweight at Piper Sandler
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

  • 01
    Jul
  • 16
    Oct
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

Earnings
Certara reports Q2 adjusted EPS 3c, consensus 5c » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
CERT

Certara

$27.99 /

+0.0398 (+0.14%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CERT Certara
$27.99 /

+0.0398 (+0.14%)

CERT Certara
$27.99 /

+0.0398 (+0.14%)

08/04/21 Credit Suisse
Certara assumed with a Neutral at Credit Suisse
07/23/21 Baird
Certara initiated with an Outperform at Baird
05/07/21 Barclays
Certara price target lowered to $35 from $40 at Barclays
03/02/21 Barclays
Certara initiated with an Overweight at Barclays
CERT Certara
$27.99 /

+0.0398 (+0.14%)

  • 25
    Mar
  • 11
    Dec
CERT Certara
$27.99 /

+0.0398 (+0.14%)

Earnings
Envestnet sees Q3 adjusted EPS 58c, consensus 49c » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
ENV

Envestnet

$74.53 /

+0.23 (+0.31%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENV Envestnet
$74.53 /

+0.23 (+0.31%)

ENV Envestnet
$74.53 /

+0.23 (+0.31%)

07/22/21 Jefferies
Envestnet downgraded to Underperform from Buy at Jefferies
05/13/21 Truist
Envestnet price target lowered to $85 from $95 at Truist
04/06/21 Jefferies
Jefferies sees Envestnet slightly beating guidance in Q1
02/26/21 RBC Capital
Envestnet price target lowered to $79 from $96 at RBC Capital
ENV Envestnet
$74.53 /

+0.23 (+0.31%)

ENV Envestnet
$74.53 /

+0.23 (+0.31%)

Earnings
Outfront Media reports Q2 EPS (5c), consensus (11c) » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
OUT

Outfront Media

$23.99 /

+0.96 (+4.17%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OUT Outfront Media
$23.99 /

+0.96 (+4.17%)

06/09/21 JPMorgan
Outfront valuation discount to Lamar should narrow, says JPMorgan
05/19/21 Citi
Outfront Media price target raised to $27 from $25 at Citi
05/06/21 Barrington
Outfront Media price target raised to $28 from $24 at Barrington
03/30/21 Morgan Stanley
Outfront Media price target raised to $24 from $22 at Morgan Stanley
OUT Outfront Media
$23.99 /

+0.96 (+4.17%)

  • 23
    Feb
Earnings
Shake Shack sees Q3 revenue $194M-$200M, consensus $198M » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
SHAK

Shake Shack

$92.68 /

+0.44 (+0.48%)

Sees Q3 same-shack sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

07/01/21 OTR Global
Shake Shack recovery trends accelerating, says OTR Global
06/07/21 Piper Sandler
Shake Shack shares remain undervalued, says Piper Sandler
05/25/21
Fly Intel: Top five analyst upgrades
05/25/21 Wedbush
Shake Shack upgraded to Outperform from Neutral at Wedbush
SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

Earnings
nLight sees Q3 revenue $68M-$74M, consensus $69.9M » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
LASR

nLight

$31.83 /

+0.51 (+1.63%)

Sees Q3 gross margin to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LASR nLight
$31.83 /

+0.51 (+1.63%)

02/18/21 DA Davidson
nLight price target raised to $48 from $30 at DA Davidson
02/18/21 Craig-Hallum
nLight price target raised to $48 from $32 at Craig-Hallum
02/18/21 Canaccord
nLight price target raised to $53 from $27 at Canaccord
01/21/21 Berenberg
nLight assumed with a Hold at Berenberg
LASR nLight
$31.83 /

+0.51 (+1.63%)

  • 04
    Mar
LASR nLight
$31.83 /

+0.51 (+1.63%)

LASR nLight
$31.83 /

+0.51 (+1.63%)

Syndicate
Karyopharm files to sell 150K shares of common stock for holders  16:56
08/05/21
08/05
16:56
08/05/21
16:56
KPTI

Karyopharm

$5.93 /

-1.905 (-24.33%)

 
ShowHide Related Items >><<
KPTI Karyopharm
$5.93 /

-1.905 (-24.33%)

KPTI Karyopharm
$5.93 /

-1.905 (-24.33%)

16:29 Today RBC Capital
Karyopharm downgraded to Sector Perform from Outperform at RBC Capital
05/04/21 Baird
Karyopharm price target lowered to $30 from $35 at Baird
05/04/21 RBC Capital
Karyopharm price target lowered to $19 from $24 at RBC Capital
02/12/21 Barclays
Karyopharm price target lowered to $22 from $26 at Barclays
KPTI Karyopharm
$5.93 /

-1.905 (-24.33%)

KPTI Karyopharm
$5.93 /

-1.905 (-24.33%)

Earnings
PlayAGS reports Q2 EPS (11c), consensus (17c) » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
AGS

PlayAGS

$8.37 /

+0.77 (+10.13%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGS PlayAGS
$8.37 /

+0.77 (+10.13%)

AGS PlayAGS
$8.37 /

+0.77 (+10.13%)

06/11/21 B. Riley
B. Riley starts PlayAGS with Buy on advantages in casino technology
06/10/21 B. Riley
PlayAGS initiated with a Buy at B. Riley
05/11/21 Credit Suisse
PlayAGS price target raised to $15 from $13 at Credit Suisse
05/07/21 Deutsche Bank
PlayAGS price target raised to $12 from $10 at Deutsche Bank
AGS PlayAGS
$8.37 /

+0.77 (+10.13%)

AGS PlayAGS
$8.37 /

+0.77 (+10.13%)

Earnings
Shake Shack reports Q2 adjusted EPS 5c, consensus (8c) » 16:56
08/05/21
08/05
16:56
08/05/21
16:56
SHAK

Shake Shack

$92.68 /

+0.44 (+0.48%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

07/01/21 OTR Global
Shake Shack recovery trends accelerating, says OTR Global
06/07/21 Piper Sandler
Shake Shack shares remain undervalued, says Piper Sandler
05/25/21
Fly Intel: Top five analyst upgrades
05/25/21 Wedbush
Shake Shack upgraded to Outperform from Neutral at Wedbush
SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

SHAK Shake Shack
$92.68 /

+0.44 (+0.48%)

Syndicate
Aptiv files automatic mixed securities shelf  16:55
08/05/21
08/05
16:55
08/05/21
16:55
APTV

Aptiv

$159.72 /

-6.39 (-3.85%)

 
ShowHide Related Items >><<
APTV Aptiv
$159.72 /

-6.39 (-3.85%)

APTV Aptiv
$159.72 /

-6.39 (-3.85%)

07/15/21 Deutsche Bank
Aptiv price target raised to $169 from $165 at Deutsche Bank
07/09/21 Jefferies
Aptiv price target raised to $182 from $170 at Jefferies
07/07/21 Barclays
Aptiv price target raised to $164 from $161 at Barclays
06/24/21 Guggenheim
Aptiv upgraded to Buy from Neutral at Guggenheim
APTV Aptiv
$159.72 /

-6.39 (-3.85%)

APTV Aptiv
$159.72 /

-6.39 (-3.85%)

APTV Aptiv
$159.72 /

-6.39 (-3.85%)

Earnings
nLight reports Q2 EPS 9c, consensus 7c » 16:55
08/05/21
08/05
16:55
08/05/21
16:55
LASR

nLight

$31.83 /

+0.51 (+1.63%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LASR nLight
$31.83 /

+0.51 (+1.63%)

02/18/21 DA Davidson
nLight price target raised to $48 from $30 at DA Davidson
02/18/21 Craig-Hallum
nLight price target raised to $48 from $32 at Craig-Hallum
02/18/21 Canaccord
nLight price target raised to $53 from $27 at Canaccord
01/21/21 Berenberg
nLight assumed with a Hold at Berenberg
LASR nLight
$31.83 /

+0.51 (+1.63%)

  • 04
    Mar
LASR nLight
$31.83 /

+0.51 (+1.63%)

LASR nLight
$31.83 /

+0.51 (+1.63%)

Earnings
Envestnet reports Q2 adjusted EPS 67c, consensus 54c » 16:55
08/05/21
08/05
16:55
08/05/21
16:55
ENV

Envestnet

$74.53 /

+0.23 (+0.31%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENV Envestnet
$74.53 /

+0.23 (+0.31%)

ENV Envestnet
$74.53 /

+0.23 (+0.31%)

07/22/21 Jefferies
Envestnet downgraded to Underperform from Buy at Jefferies
05/13/21 Truist
Envestnet price target lowered to $85 from $95 at Truist
04/06/21 Jefferies
Jefferies sees Envestnet slightly beating guidance in Q1
02/26/21 RBC Capital
Envestnet price target lowered to $79 from $96 at RBC Capital
ENV Envestnet
$74.53 /

+0.23 (+0.31%)

ENV Envestnet
$74.53 /

+0.23 (+0.31%)

Earnings
Nephros reports Q2 EPS (12c), consensus (10c) » 16:55
08/05/21
08/05
16:55
08/05/21
16:55
NEPH

Nephros

$8.25 /

-0.1 (-1.20%)

Reports Q2 revenue $2.3M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEPH Nephros
$8.25 /

-0.1 (-1.20%)

NEPH Nephros
$8.25 /

-0.1 (-1.20%)

01/26/21 B. Riley Securities
Nephros initiated with a Buy, $12.50 target at B. Riley Securities
01/26/21 B. Riley Securities
Nephros initiated with a Buy at B. Riley Securities
NEPH Nephros
$8.25 /

-0.1 (-1.20%)

Earnings
Cryoport reports Q2 EPS (16c), consensus (13c) » 16:54
08/05/21
08/05
16:54
08/05/21
16:54
CYRX

Cryoport

$64.96 /

+1.945 (+3.09%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYRX Cryoport
$64.96 /

+1.945 (+3.09%)

CYRX Cryoport
$64.96 /

+1.945 (+3.09%)

07/16/21
Fly Intel: Top five analyst initiations
07/16/21 BTIG
Cryoport initiated with a Buy at BTIG
03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
CYRX Cryoport
$64.96 /

+1.945 (+3.09%)

  • 21
    Jan
Earnings
Procore sees FY21 revenue $496M-$499M, consensus $488.74M » 16:54
08/05/21
08/05
16:54
08/05/21
16:54
PCOR

Procore

$98.06 /

-3.94 (-3.86%)

Sees FY21 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCOR Procore
$98.06 /

-3.94 (-3.86%)

PCOR Procore
$98.06 /

-3.94 (-3.86%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Canaccord
Procore initiated with a Buy, $100 target at Canaccord
06/14/21 JPMorgan
Procore initiated with an Overweight at JPMorgan
06/14/21 William Blair
Procore initiated with an Outperform at William Blair
PCOR Procore
$98.06 /

-3.94 (-3.86%)

  • 20
    May
PCOR Procore
$98.06 /

-3.94 (-3.86%)

PCOR Procore
$98.06 /

-3.94 (-3.86%)

Earnings
Nektar reports Q2 EPS (69c), consensus (74c) » 16:54
08/05/21
08/05
16:54
08/05/21
16:54
NKTR

Nektar

$15.86 /

+0.26 (+1.67%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKTR Nektar
$15.86 /

+0.26 (+1.67%)

NKTR Nektar
$15.86 /

+0.26 (+1.67%)

06/28/21
Fly Intel: Top five analyst upgrades
06/28/21 Stifel
Stifel upgrades Nektar to Buy ahead of lung cancer data
06/28/21 Stifel
Nektar upgraded to Buy from Hold at Stifel
05/18/21 Goldman Sachs
Nektar assumed with a Neutral at Goldman Sachs
NKTR Nektar
$15.86 /

+0.26 (+1.67%)

NKTR Nektar
$15.86 /

+0.26 (+1.67%)

Earnings
Velodyne Lidar sees FY21 revenue $77M-$94M, consensus $85.87M » 16:54
08/05/21
08/05
16:54
08/05/21
16:54
VLDR

Velodyne Lidar

$7.62 /

+0.02 (+0.26%)

Non-GAAP Gross margins…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

07/20/21 Baird
Baird downgrades Velodyne Lidar on 'further uncertainty' after CEO exit
07/20/21 Baird
Velodyne Lidar downgraded to Neutral from Outperform at Baird
05/11/21 Needham
Velodyne Lidar price target lowered to $15 from $20 at Needham
04/20/21 BofA
Velodyne Lidar initiated with an Underperform at BofA
VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

Earnings
Procore sees Q3 revenue $125M-$127M, consensus $123.43M » 16:54
08/05/21
08/05
16:54
08/05/21
16:54
PCOR

Procore

$98.06 /

-3.94 (-3.86%)

Sees Q3 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PCOR Procore
$98.06 /

-3.94 (-3.86%)

PCOR Procore
$98.06 /

-3.94 (-3.86%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Canaccord
Procore initiated with a Buy, $100 target at Canaccord
06/14/21 JPMorgan
Procore initiated with an Overweight at JPMorgan
06/14/21 William Blair
Procore initiated with an Outperform at William Blair
PCOR Procore
$98.06 /

-3.94 (-3.86%)

  • 20
    May
PCOR Procore
$98.06 /

-3.94 (-3.86%)

PCOR Procore
$98.06 /

-3.94 (-3.86%)

Earnings
Iteris sees FY21 revenue $134M-$142M, consensus $138.1M » 16:54
08/05/21
08/05
16:54
08/05/21
16:54
ITI

Iteris

$6.04 /

+ (+0.00%)

Iteris also…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITI Iteris
$6.04 /

+ (+0.00%)

ITI Iteris
$6.04 /

+ (+0.00%)

03/02/21 Northland
Rekor unlikely to increase offer for Iteris, says Northland
12/08/20 B. Riley Securities
Iteris price target raised to $9 from $8.50 at B. Riley Securities
ITI Iteris
$6.04 /

+ (+0.00%)

ITI Iteris
$6.04 /

+ (+0.00%)

Earnings
Velodyne Lidar reports Q2 adjusted EPS (18c), consensus (14c) » 16:53
08/05/21
08/05
16:53
08/05/21
16:53
VLDR

Velodyne Lidar

$7.62 /

+0.02 (+0.26%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

07/20/21 Baird
Baird downgrades Velodyne Lidar on 'further uncertainty' after CEO exit
07/20/21 Baird
Velodyne Lidar downgraded to Neutral from Outperform at Baird
05/11/21 Needham
Velodyne Lidar price target lowered to $15 from $20 at Needham
04/20/21 BofA
Velodyne Lidar initiated with an Underperform at BofA
VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

VLDR Velodyne Lidar
$7.62 /

+0.02 (+0.26%)

Earnings
Procore Technologies reports Q2 EPS (50c), consensus (14c) » 16:53
08/05/21
08/05
16:53
08/05/21
16:53
PCOR

Procore

$98.06 /

-3.94 (-3.86%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCOR Procore
$98.06 /

-3.94 (-3.86%)

PCOR Procore
$98.06 /

-3.94 (-3.86%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Canaccord
Procore initiated with a Buy, $100 target at Canaccord
06/14/21 JPMorgan
Procore initiated with an Overweight at JPMorgan
06/14/21 William Blair
Procore initiated with an Outperform at William Blair
  • 20
    May
PCOR Procore
$98.06 /

-3.94 (-3.86%)

PCOR Procore
$98.06 /

-3.94 (-3.86%)

Earnings
Vimeo reports Q2 EPS (13c), consensus (4c) » 16:53
08/05/21
08/05
16:53
08/05/21
16:53
VMEO

Vimeo

$45.13 /

-0.59 (-1.29%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VMEO Vimeo
$45.13 /

-0.59 (-1.29%)

VMEO Vimeo
$45.13 /

-0.59 (-1.29%)

07/22/21
Fly Intel: Top five analyst initiations
07/22/21 JPMorgan
Vimeo initiated with a Neutral at JPMorgan
07/21/21
Fly Intel: Top five analyst initiations
07/21/21 BMO Capital
Vimeo initiated with a Market Perform at BMO Capital
VMEO Vimeo
$45.13 /

-0.59 (-1.29%)

VMEO Vimeo
$45.13 /

-0.59 (-1.29%)

Earnings
Iteris reports Q1 GAAP EPS 1c, consensus 3c » 16:53
08/05/21
08/05
16:53
08/05/21
16:53
ITI

Iteris

$6.04 /

+ (+0.00%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITI Iteris
$6.04 /

+ (+0.00%)

ITI Iteris
$6.04 /

+ (+0.00%)

03/02/21 Northland
Rekor unlikely to increase offer for Iteris, says Northland
12/08/20 B. Riley Securities
Iteris price target raised to $9 from $8.50 at B. Riley Securities
ITI Iteris
$6.04 /

+ (+0.00%)

ITI Iteris
$6.04 /

+ (+0.00%)

Earnings
CytomX Therapeutics reports Q2 EPS (30c), consensus (32c) » 16:53
08/05/21
08/05
16:53
08/05/21
16:53
CTMX

CytomX Therapeutics

$5.77 /

+0.21 (+3.78%)

Reports Q2 revenue $16M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTMX CytomX Therapeutics
$5.77 /

+0.21 (+3.78%)

CTMX CytomX Therapeutics
$5.77 /

+0.21 (+3.78%)

05/28/21 Barclays
CytomX Therapeutics downgraded to Underweight from Equal Weight at Barclays
03/29/21
Fly Intel: Top five analyst initiations
03/29/21 JPMorgan
CytomX Therapeutics initiated with an Overweight at JPMorgan
03/23/21 Jefferies
CytomX Therapeutics upgraded to Buy from Hold at Jefferies
CTMX CytomX Therapeutics
$5.77 /

+0.21 (+3.78%)

  • 21
    Jan
Earnings
Brookdale Senior Living reports Q2 EPS (45c), consensus (49c) » 16:52
08/05/21
08/05
16:52
08/05/21
16:52
BKD

Brookdale Senior Living

$7.32 /

+0.125 (+1.74%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKD Brookdale Senior Living
$7.32 /

+0.125 (+1.74%)

BKD Brookdale Senior Living
$7.32 /

+0.125 (+1.74%)

06/22/21 Stifel
Brookdale Senior Living resumed with a Buy at Stifel
06/11/21 Barclays
Brookdale Senior Living upgraded to Overweight from Equal Weight at Barclays
06/07/21 Jefferies
Approval of Biogen Alzheimer's drug could be catalyst for RadNet, says Jefferies
03/09/21 RBC Capital
Brookdale Senior Living price target raised to $7 from $4 at RBC Capital
BKD Brookdale Senior Living
$7.32 /

+0.125 (+1.74%)

BKD Brookdale Senior Living
$7.32 /

+0.125 (+1.74%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.